5-benzyl-9-hydroxyindeno[1,2-b]indole-10(5H)-one | 958785-40-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-benzyl-9-hydroxyindeno[1,2-b]indole-10(5H)-one
• 英文别名: 5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one；5-benzyl-9-hydroxyindeno[1,2-b]indol-10-one
• CAS: 958785-40-5
• 化学式: C₂₂H₁₅NO₂
• 分子量: 325.367
• InChiKey: KBWYFFCXQKUBNZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  25
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-benzyl-9-hydroxyindeno[1,2-b]indole-10(5H)-one 在 salcomine 、 氧气 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 8.0h， 以62%的产率得到5-benzyl-5H-indeno[1,2-b]indole-6,9,10-trione
  参考文献：
  名称：

  Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines

  摘要：

  We previously reported indeno[1,2-b]indoles as a novel class of potent inhibitors of the human protein kinase CK2. In the present study we prepared two novel quinoid derivatives, the indeno[1,2-b]indoloquinones 6b and 6c, and demonstrated inhibition of the human CK2 by the compounds. Furthermore, we showed substantial antiproliferative activity of both compounds towards a broad panel of human cancer cell lines in the low micromolar range. Whereas the earlier indeno[1,2-b]indoles have been shown to be selective for CK2, the indeno[1,2-b]indoloquinones 6b and 6c also inhibited the AMPK activated protein kinase ARK5, potentially contributing to the anti-cancer effects of the compounds. In addition, with compound 6b we found a very potent inhibitor of the leukemia-associated receptor tyrosine kinase FLT3, with an IC50 of 0.18 mu M. (C) 2012 Elsevier Inc. All rights reserved.

  DOI：

  10.1016/j.bbrc.2012.06.068
• 作为产物：
  描述：

  N-benzyl-3-amino-2-cyclohexen-1-one 在 N,N,N',N'-四甲基磺酰胺 、 溶剂黄146 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 为溶剂， 反应 75.0h， 生成 5-benzyl-9-hydroxyindeno[1,2-b]indole-10(5H)-one
  参考文献：
  名称：

  茚并[1,2- b ]吲哚衍生物作为一类新型的有效人类蛋白激酶CK2抑制剂

  摘要：

  在这里，我们描述了茚并[1,2- b ]吲哚衍生物的合成及其性质，它们是一类新型的人类蛋白激酶CK2的有效抑制剂。使用方便和直接的合成方案获得了一组19种化合物。测试了化合物对在大肠杆菌中重组表达的人蛋白激酶CK2的抑制作用。鉴定出IC 50在微摩尔和亚微摩尔范围内的新抑制剂。化合物4b（5-异丙基-7,8-二氢茚并[1,2- b ]吲哚-9,10（5 H，6 H）-二酮）抑制人CK2的IC 50浓度为0.11μM，并且没有显着抑制22种其他人类蛋白激酶，表明对CK2具有选择性。显示了化合物4b对ATP的竞争抑制作用，确定的K i为0.06μM。我们的发现表明，茚并[1,2- b ]吲哚是进一步开发和优化人类蛋白激酶CK2抑制剂的有希望的起点。

  DOI：

  10.1016/j.bmc.2012.02.017

文献信息

• Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines
  作者：Claas Hundsdörfer、Hans-Jörg Hemmerling、Janina Hamberger、Marc Le Borgne、Patrick Bednarski、Claudia Götz、Frank Totzke、Joachim Jose

  DOI：10.1016/j.bbrc.2012.06.068

  日期：2012.7

  We previously reported indeno[1,2-b]indoles as a novel class of potent inhibitors of the human protein kinase CK2. In the present study we prepared two novel quinoid derivatives, the indeno[1,2-b]indoloquinones 6b and 6c, and demonstrated inhibition of the human CK2 by the compounds. Furthermore, we showed substantial antiproliferative activity of both compounds towards a broad panel of human cancer cell lines in the low micromolar range. Whereas the earlier indeno[1,2-b]indoles have been shown to be selective for CK2, the indeno[1,2-b]indoloquinones 6b and 6c also inhibited the AMPK activated protein kinase ARK5, potentially contributing to the anti-cancer effects of the compounds. In addition, with compound 6b we found a very potent inhibitor of the leukemia-associated receptor tyrosine kinase FLT3, with an IC50 of 0.18 mu M. (C) 2012 Elsevier Inc. All rights reserved.
• Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors
  作者：Claas Hundsdörfer、Hans-Jörg Hemmerling、Claudia Götz、Frank Totzke、Patrick Bednarski、Marc Le Borgne、Joachim Jose

  DOI：10.1016/j.bmc.2012.02.017

  日期：2012.4

  Herein we describe the synthesis and properties of indeno[1,2-b]indole derivatives as a novel class of potent inhibitors of the human protein kinase CK2. A set of 19 compounds was obtained using a convenient and straightforward synthesis protocol. The compounds were tested for inhibition of human protein kinase CK2, which was recombinantly expressed in Escherichia coli. New inhibitors with IC50 in the micro-

  在这里，我们描述了茚并[1,2- b ]吲哚衍生物的合成及其性质，它们是一类新型的人类蛋白激酶CK2的有效抑制剂。使用方便和直接的合成方案获得了一组19种化合物。测试了化合物对在大肠杆菌中重组表达的人蛋白激酶CK2的抑制作用。鉴定出IC 50在微摩尔和亚微摩尔范围内的新抑制剂。化合物4b（5-异丙基-7,8-二氢茚并[1,2- b ]吲哚-9,10（5 H，6 H）-二酮）抑制人CK2的IC 50浓度为0.11μM，并且没有显着抑制22种其他人类蛋白激酶，表明对CK2具有选择性。显示了化合物4b对ATP的竞争抑制作用，确定的K i为0.06μM。我们的发现表明，茚并[1,2- b ]吲哚是进一步开发和优化人类蛋白激酶CK2抑制剂的有希望的起点。